Precigen Inc (PGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -170,521 | -323,916 | -514,706 | -126,820 | -190,274 |
| Depreciation Amortization | 37,145 | 113,379 | 66,919 | 28,970 | 84,536 |
| Income taxes - deferred | -156 | -3,674 | -21,278 | -2,528 | -3,467 |
| Accounts receivable | 4,325 | 49 | 7,763 | 2,032 | 9,621 |
| Accounts payable and accrued liabilities | -1,130 | -5,304 | 4,628 | -3,549 | 3,928 |
| Other Working Capital | -20,651 | 2,429 | -19,985 | -74,160 | -10,752 |
| Other Operating Activity | 73,967 | 81,110 | 352,419 | 72,335 | 57,420 |
| Operating Cash Flow | $-77,021 | $-135,927 | $-124,240 | $-103,720 | $-48,988 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -55,073 | -178,681 | -2,061 | N/A |
| PPE Investments | -1,043 | -37,195 | -39,320 | -45,030 | -31,355 |
| Net Acquisitions | N/A | -7,244 | 14,580 | -12,165 | -7,244 |
| Purchase Of Investment | -171,360 | -3,713 | -16,582 | -11,189 | -89,096 |
| Sale Of Investment | 133,000 | 189,951 | 66,192 | 174,777 | 102,267 |
| Other Investing Activity | 67,182 | 125 | 2,598 | 0 | -2,964 |
| Investing Cash Flow | $27,779 | $86,851 | $-151,213 | $104,332 | $-28,392 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,005 | 11,757 | 4,561 | 5,906 | 5,075 |
| Debt Issued | N/A | 376 | 219,859 | 325 | 547 |
| Debt Repayment | -490 | -618 | -623 | -519 | -1,201 |
| Common Stock Issued | 35,117 | 6,924 | 90,326 | 14,666 | 19,165 |
| Other Financing Activity | -11,927 | -10,301 | -4,328 | -16,094 | -11,521 |
| Financing Cash Flow | $32,705 | $8,138 | $309,795 | $4,284 | $12,065 |
| Exchange Rate Effect | 353 | -810 | 295 | 1,055 | -873 |
| Beginning Cash Position | 68,434 | 110,182 | 75,545 | 69,594 | 135,782 |
| End Cash Position | 52,250 | 68,434 | 110,182 | 75,545 | 69,594 |
| Net Cash Flow | $-16,184 | $-41,748 | $34,637 | $5,951 | $-66,188 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,021 | -135,927 | -124,240 | -103,720 | -48,988 |
| Capital Expenditure | -7,527 | -37,883 | -41,587 | -46,666 | -31,629 |
| Free Cash Flow | -84,548 | -173,810 | -165,827 | -150,386 | -80,617 |